NDC 0591-3204

Podofilox

Podofilox

Podofilox is a Topical Solution in the Human Prescription Drug category. It is labeled and distributed by Actavis Pharma, Inc.. The primary component is Podofilox.

• Product ID: 0591-3204_5766dbf4-7685-44be-b45b-cee2076b8fee
• NDC: 0591-3204
• Product Type: Human Prescription Drug
• Proprietary Name: Podofilox
• Generic Name: Podofilox
• Dosage Form: Solution
• Route of Administration: TOPICAL
• Marketing Start Date: 1990-12-13
• Marketing Category: NDA AUTHORIZED GENERIC / NDA AUTHORIZED GENERIC
• Application Number: NDA019795
• Labeler Name: Actavis Pharma, Inc.
• Substance Name: PODOFILOX
• Active Ingredient Strength: 5 mg/mL
• Pharm Classes: Decreased Mitosis [PE]
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 0591-3204-13

3.5 mL in 1 BOTTLE, GLASS (0591-3204-13)

• Marketing Start Date: 1990-12-13
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 0591-3204-13 [00591320413]

Podofilox SOLUTION

• Marketing Category: NDA AUTHORIZED GENERIC
• Application Number: NDA019795
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: ML
• Marketing Start Date: 1990-12-13

Drug Details

Active Ingredients

Ingredient	Strength
PODOFILOX	5 mg/mL

OpenFDA Data

• SPL SET ID: affc1058-7355-4486-8b65-378fea6f9454
• Manufacturer:
  • Actavis Pharma, Inc.
• UNII:
  • L36H50F353
• RxNorm Concept Unique ID - RxCUI:
  • 582926

Pharmacological Class

• Decreased Mitosis [PE]
• Decreased Mitosis [PE]

NDC Crossover Matching brand name "Podofilox" or generic name "Podofilox"

NDC	Brand Name	Generic Name
0574-0611	PODOFILOX	PODOFILOX
0591-3204	Podofilox	Podofilox
63629-8832	Podofilox	Podofilox
0023-6118	Condylox	podofilox